|
Resveratrol mitigates diabetes-induced cardiac dysfunction via SIRT1/PPAR-α/PGC-1 pathway. Mol Genet Genomics Fu R, Hao J. PMID: 41348235 [PubMed - indexed for MEDLINE]
|
|
Cost-effectiveness of a single-layer high compression bandage versus Unna's boot for venous leg ulcer treatment: the VENOS trial. J Wound Care Fuhrmann AC, Cordova FP, Machado DO, Mocellin D, Johnson JA, Paskulin LMG. PMID: 41348198 [PubMed - indexed for MEDLINE]
|
|
Application of telemedicine in home healthcare for patients with diabetic foot ulcers: a randomised controlled study. J Wound Care Hai-Ping Y, Hui-Ren Z, Ying-Jie G, Xiao-Jing L, Hung YY, Jia-Li Y, Yi-Li G. PMID: 41348195 [PubMed - indexed for MEDLINE]
|
|
Arterial wall enhancement on high-resolution vessel-wall MRI correlates with stenosis burden and large-artery atherosclerosis subtype in ischemic stroke. Neurosurg Rev Zheng Q, Gong T. PMID: 41348180 [PubMed - indexed for MEDLINE]
|
|
CAR T-cell therapy and bispecific antibodies in the management of multiple myeloma. Hematology Am Soc Hematol Educ Program Dima D, Banerjee R, Hansen DK. PMID: 41348052 [PubMed - indexed for MEDLINE]
|
|
Anticoagulants in hematologic malignancies: what is the data? Hematology Am Soc Hematol Educ Program Alyamany R, Houghton DE. PMID: 41348050 [PubMed - indexed for MEDLINE]
|
|
Can I stop my treatment, doctor? Is MRD-guided therapy ready for prime time? Hematology Am Soc Hematol Educ Program Derman BA. PMID: 41348032 [PubMed - indexed for MEDLINE]
|
|
How to approach the high-risk myeloma from induction through relapse? Hematology Am Soc Hematol Educ Program Weisel KC, Schaefers C, Leypoldt LB. PMID: 41348031 [PubMed - indexed for MEDLINE]
|
|
Transplant in myeloma: what is its role? Hematology Am Soc Hematol Educ Program Rodriguez C. PMID: 41348025 [PubMed - indexed for MEDLINE]
|
|
What is the best induction for myeloma for the fit patient? Hematology Am Soc Hematol Educ Program Shah NN, Kaufman JL. PMID: 41348024 [PubMed - indexed for MEDLINE]
|
|
Choosing the optimal maintenance strategy in multiple myeloma. Hematology Am Soc Hematol Educ Program Puliafito B, Cirstea D, Raje N. PMID: 41348019 [PubMed - indexed for MEDLINE]
|
|
Implementation failure: thromboprophylaxis in ambulatory patients with cancer. Hematology Am Soc Hematol Educ Program Butera E, Wang TF, Pola R, Carrier M. PMID: 41348016 [PubMed - indexed for MEDLINE]
|
|
Managing patients with a history of arterial disease and new venous thromboembolism. Hematology Am Soc Hematol Educ Program Deng E, Passam FH. PMID: 41348011 [PubMed - indexed for MEDLINE]
|
|
Updates in antithrombotic therapy in coronary and peripheral artery disease. Hematology Am Soc Hematol Educ Program Pollak AW. PMID: 41348008 [PubMed - indexed for MEDLINE]
|
|
When sickle cell trait is not just trait: risk of VTE. Hematology Am Soc Hematol Educ Program Naik RP, Pawlinski R, Key NS. PMID: 41348002 [PubMed - indexed for MEDLINE]
|
|
Sickle cell disease: managing thromboembolism. Hematology Am Soc Hematol Educ Program Babu K, Wun T. PMID: 41347992 [PubMed - indexed for MEDLINE]
|
|
Endless possibilities and how to exploit them? What is the optimal treatment sequence? Hematology Am Soc Hematol Educ Program Chakraborty R, Bhutani D, Lentzsch S. PMID: 41347981 [PubMed - indexed for MEDLINE]
|
|
Cryptogenic stroke: definitions and management. Hematology Am Soc Hematol Educ Program Powers WJ. PMID: 41347980 [PubMed - indexed for MEDLINE]
|
|
Anticoagulation in malignancy: the patient who bleeds and clots simultaneously. Hematology Am Soc Hematol Educ Program Kapoor S, Peseski AM, Ortel TL. PMID: 41347979 [PubMed - indexed for MEDLINE]
|
|
What's new in hereditary hemorrhagic telangiectasia? Hematology Am Soc Hematol Educ Program Kasthuri RS. PMID: 41347972 [PubMed - indexed for MEDLINE]
|
| |
|
 |
 |